{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:16:01Z","timestamp":1770959761635,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["BES-2012-052719"],"award-info":[{"award-number":["BES-2012-052719"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009579","name":"Oxalosis and Hyperoxaluria Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-096246-B-I00"],"award-info":[{"award-number":["RTI2018-096246-B-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RTI2018-098560-B-C21"],"award-info":[{"award-number":["RTI2018-098560-B-C21"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016970","name":"Consejer\u00eda de Econom\u00eda, Conocimiento, Empresas y Universidad, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P18-RT-2413"],"award-info":[{"award-number":["P18-RT-2413"]}],"id":[{"id":"10.13039\/100016970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006393","name":"Universidad de Granada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006393","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejmech.2022.114396","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T20:08:05Z","timestamp":1650917285000},"page":"114396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production"],"prefix":"10.1016","volume":"237","author":[{"given":"Maria Dolores","family":"Moya-Garzon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Rodriguez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Martin-Higueras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Franco-Montalban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1840-616X","authenticated-orcid":false,"given":"Miguel X.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Gomez-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-3243","authenticated-orcid":false,"given":"Angel L.","family":"Pey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Salido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7868-7231","authenticated-orcid":false,"given":"Monica","family":"Diaz-Gavilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114396_bib1","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1021\/acs.jmedchem.8b00399","article-title":"Salicylic acid derivatives inhibit oxalate production in mouse hepatocytes with primary hyperoxaluria type 1","volume":"61","author":"Moya-Garz\u00f3n","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-2836(03)00791-5","article-title":"Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1","volume":"331","author":"Zhang","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2022.114396_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/mt.2015.224","article-title":"Glycolate oxidase is a safe and efficient target for substrate reduction therapy in a mouse model of primary hyperoxaluria type I","volume":"24","author":"Martin-Higueras","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2022.114396_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/humu.9200","article-title":"Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2","volume":"22","author":"Cregeen","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmech.2022.114396_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ajhg.2010.07.023","article-title":"Mutations in DHDPSL are responsible for primary hyperoxaluria type III","volume":"87","author":"Belostotsky","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmech.2022.114396_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2019.08.018","article-title":"Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up","author":"Garrelfs","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2022.114396_bib7","article-title":"HOGA1 gene mutations of primary hyperoxaluria type 3 in Tunisian patients","volume":"31","author":"M\u2019dimegh","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.ejmech.2022.114396_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0004563216677101","article-title":"Late diagnosis of primary hyperoxaluria type III","volume":"54","author":"Richard","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ejmech.2022.114396_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2021.03.031","article-title":"A report from the European Hyperoxaluria Consortium (OxalEurope) Registry on a large cohort of patients with primary hyperoxaluria type 3","author":"Martin-Higueras","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2022.114396_bib10","article-title":"Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study","author":"Singh","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2022.114396_bib11","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","article-title":"Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele","volume":"67","author":"Monico","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2022.114396_bib12","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbadis.2013.04.010","article-title":"Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1","volume":"1832","author":"Fargue","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2022.114396_bib13","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bbadis.2012.03.004","article-title":"Primary hyperoxalurias: disorders of glyoxylate detoxification","volume":"1822","author":"Salido","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2022.114396_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1056\/NEJMra1301564","article-title":"Primary hyperoxaluria","volume":"369","author":"Cochat","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114396_bib15","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1042\/BCJ20190507","article-title":"Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1","volume":"476","author":"Dindo","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2022.114396_bib16","doi-asserted-by":"crossref","first-page":"165633","DOI":"10.1016\/j.bbadis.2019.165633","article-title":"The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria","volume":"1866","author":"Buchalski","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2022.114396_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14728214.2018.1552940","article-title":"Novel therapeutic approaches in primary hyperoxaluria","volume":"23","author":"Weigert","year":"2018","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2022.114396_bib18","article-title":"Novel therapeutic approaches for the primary hyperoxalurias","author":"Belostotsky","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114396_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40265-020-01463-0","article-title":"Lumasiran: first approval","volume":"81","author":"Scott","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2022.114396_bib20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa2021712","article-title":"Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1","volume":"384","author":"Garrelfs","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114396_bib21","series-title":"Methods for Inhibition of Hao1 (Hydroxyacid Oxidase 1 (Glycolate Oxidase) Gene Expression, WO2019014491A1","author":"Erbe","year":"2019"},{"key":"10.1016\/j.ejmech.2022.114396_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nbt0918-777","article-title":"Alnylam launches era of RNAi drugs","volume":"36","author":"Garber","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2022.114396_bib23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.ymthe.2018.05.016","article-title":"Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria","volume":"26","author":"Lai","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2022.114396_bib24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ekir.2021.01.029","article-title":"Hepatic lactate dehydrogenase A: an RNA interference target for the treatment of all known types of primary hyperoxaluria","volume":"6","author":"Ariceta","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"21","key":"10.1016\/j.ejmech.2022.114396_bib25","first-page":"S0085","article-title":"Safety, pharmacodynamics, and exposure-response modeling results from a first in human phase 1 study of nedosiran in primary hyperoxaluria","author":"Hoppe","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejmech.2022.114396_bib26","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI99822","article-title":"Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning","volume":"129","author":"Dudal","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.114396_bib27","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00467-020-04585-5","article-title":"Stiripentol fails to lower plasma oxalate in a dialysis-dependent PH1 patient","volume":"35","author":"Kempf","year":"2020","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ejmech.2022.114396_bib28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MNH.0000000000000621","article-title":"Stiripentol identifies a therapeutic target to reduce oxaluria","volume":"29","author":"Letavernier","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejmech.2022.114396_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.06.028","article-title":"Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors","volume":"101","author":"Rupiani","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib30","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2022.114396_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1138367","article-title":"Evolution of a gene","volume":"189","author":"Markert","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114396_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1021\/acsmedchemlett.1c00196","article-title":"Dual glycolate oxidase\/lactate dehydrogenase A inhibitors for primary hyperoxaluria","volume":"12","author":"Ding","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114396_bib33","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1021\/bi701710r","article-title":"Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design","volume":"47","author":"Murray","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2022.114396_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1139\/v78-100","article-title":"Intermediates in the cycloanhydrotetramerization of furan with aliphatic and alicyclic ketones","volume":"56","author":"Brown","year":"1978","journal-title":"Can. J. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib35","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1021\/ma951522f","article-title":"Acid-catalyzed polycondensation of furfuryl alcohol: mechanisms of chromophore formation and cross-linking","volume":"29","author":"Choura","year":"1996","journal-title":"Macromolecules"},{"issue":"n.d.","key":"10.1016\/j.ejmech.2022.114396_bib36","first-page":"1690","article-title":"Furfuryl alcohol in synthesis of levulinic acid esters and difurylmethane with Fe and Rh complexes","volume":"80","author":"Khusnutdinov","year":"1687","journal-title":"Russ. J. Appl. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcat.2014.02.012","article-title":"Biomass conversion to diesel via the etherification of furanyl alcohols catalyzed by Amberlyst-15","volume":"313","author":"Sacia","year":"2014","journal-title":"J. Catal."},{"key":"10.1016\/j.ejmech.2022.114396_bib38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.catcom.2013.11.030","article-title":"Thermodynamics and reaction pathways of furfuryl alcohol oligomer formation","volume":"46","author":"Kim","year":"2014","journal-title":"Catal. Commun."},{"key":"10.1016\/j.ejmech.2022.114396_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ardp.19863190406","article-title":"Zur chemischen Stabilit\u00e4t von Furfenorex und analogen Modellsubstanzen","volume":"319","author":"R\u00fccker","year":"1986","journal-title":"Arch. Pharm. Pharm. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/med.2610150406","article-title":"Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism","volume":"15","author":"Kalgutkar","year":"1995","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114396_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejmech.2019.05.039","article-title":"Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase","volume":"177","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbapap.2005.08.004","article-title":"A preliminary account of the properties of recombinant human Glyoxylate reductase (GRHPR), LDHA and LDHB with glyoxylate, and their potential roles in its metabolism","volume":"1753","author":"Mdluli","year":"2005","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2022.114396_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1747-0285.2010.00972.x","article-title":"Non-competitive inhibition by active site binders","volume":"75","author":"Blat","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114396_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijbiomac.2011.03.016","article-title":"Exploring glycolate oxidase (GOX) as an antiurolithic drug target: molecular modeling and in vitro inhibitor study","volume":"49","author":"Shirfule","year":"2011","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2022.114396_bib46","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1021\/acsomega.0c00715","article-title":"Structural evidence for isoform-selective allosteric inhibition of lactate dehydrogenase A","volume":"5","author":"Friberg","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.114396_bib47","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1021\/acs.jpclett.6b01209","article-title":"Targeting a rate-promoting vibration with an allosteric mediator in lactate dehydrogenase","volume":"7","author":"Dzierlenga","year":"2016","journal-title":"J. Phys. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114396_bib48","doi-asserted-by":"crossref","first-page":"18249","DOI":"10.1073\/pnas.0607218103","article-title":"Alanine-glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer","volume":"103","author":"Salido","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2022.114396_bib49","doi-asserted-by":"crossref","first-page":"F688","DOI":"10.1152\/ajprenal.00473.2011","article-title":"Hydroxyproline metabolism in mouse models of primary hyperoxaluria","volume":"302","author":"Knight","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejmech.2022.114396_bib50","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bbadis.2015.09.016","article-title":"Hydroxyproline metabolism in a mouse model of primary hyperoxaluria type 3","volume":"1852","author":"Li","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2022.114396_bib51","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/pro.5560060506","article-title":"Three-dimensional structures of glycolate oxidase with bound active-site inhibitors","volume":"6","author":"Stenberg","year":"1997","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2022.114396_bib52","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1107\/S1399004714005422","article-title":"Structural characterization of the apo form and NADH binary complex of human lactate dehydrogenase","volume":"70","author":"Dempster","year":"2014","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114396_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#","article-title":"Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase","volume":"43","author":"Read","year":"2001","journal-title":"Protein. Struct. Funct. Bioinf."},{"key":"10.1016\/j.ejmech.2022.114396_bib54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bmcl.2014.11.008","article-title":"Optimization of 5-(2,6-dichlorophenyl)-3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase","volume":"25","author":"Labadie","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114396_bib55","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/j.bmcl.2013.04.001","article-title":"Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase","volume":"23","author":"Dragovich","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114396_bib56","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.bmcl.2013.08.060","article-title":"Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase","volume":"23","author":"Fauber","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114396_bib57","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/jm3014844","article-title":"Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors","volume":"56","author":"Kohlmann","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib58","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1021\/jm201734r","article-title":"Design and synthesis of novel lactate dehydrogenase A inhibitors by fragment-based lead generation","volume":"55","author":"Ward","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1107\/S1399004714024791","article-title":"Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms","volume":"71","author":"Kolappan","year":"2015","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2022.114396_bib61","doi-asserted-by":"crossref","first-page":"12253","DOI":"10.1073\/pnas.0704304104","article-title":"Reaction coordinate of an enzymatic reaction revealed by transition path sampling","volume":"104","author":"Quaytman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2022.114396_bib62","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/jp400376h","article-title":"Changes in protein architecture and subpicosecond protein dynamics impact the reaction catalyzed by lactate dehydrogenase","volume":"117","author":"Masterson","year":"2013","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib63","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1073\/pnas.0608659104","article-title":"Activity-based probes for proteomic profiling of histone deacetylase complexes","volume":"104","author":"Salisbury","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2022.114396_bib64","doi-asserted-by":"crossref","first-page":"34060","DOI":"10.1038\/srep34060","article-title":"High throughput cell-based assay for identification of glycolate oxidase inhibitors as a potential treatment for Primary Hyperoxaluria Type 1","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2022.114396_bib65","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1016\/j.bmcl.2014.06.076","article-title":"Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase","volume":"24","author":"Dragovich","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114396_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative protein structure modeling using Modeller","author":"Eswar","year":"2006","journal-title":"Curr.Protoc.Bioinf."},{"key":"10.1016\/j.ejmech.2022.114396_bib67","author":"UniProt"},{"key":"10.1016\/j.ejmech.2022.114396_bib68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2022.114396_bib69","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock 4 and AutoDockTools 4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2022.114396_bib70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2022.114396_bib71","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2022.114396_bib72","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2022.114396_bib73","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:44:48Z","timestamp":1759329888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":71,"alternative-id":["S0223523422002987"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114396","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114396"}}